| Jayson A Lord, MD | |
|
212 N 2nd St, Leesburg, FL 34748-5103 | |
| (352) 435-0723 | |
| Not Available |
| Full Name | Jayson A Lord |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 29 Years |
| Location | 212 N 2nd St, Leesburg, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285625046 | NPI | - | NPPES |
| 256879902 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | ME72864 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spinecare Associates, Llc | 5496649493 | 12 |
| University Diagnostic Institute Winter Park Pllc | 5991607871 | 8 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.
If videogames like "Madden NFL" didn't exist, 12-year-old Tom might go outside and toss around a real football - and he'd have a better chance of sprinting for a touchdown without getting winded.
New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) highlights the benefits of total knee replacement (TKR) in elderly patients with osteoarthritis, including a lower probability of heart failure and mortality.
Researchers at the Universit- Laval Faculty of Medicine, the Quebec Heart and Lung Institute Research Center, and the Institute of Nutrition and Functional Foods have discovered a natural molecule that could be used to treat insulin resistance and type 2 diabetes.
› Verified 7 days ago
| Entity Name | University Diagnostic Institute Winter Park Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417917253 PECOS PAC ID: 5991607871 Enrollment ID: O20040122000010 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.
If videogames like "Madden NFL" didn't exist, 12-year-old Tom might go outside and toss around a real football - and he'd have a better chance of sprinting for a touchdown without getting winded.
New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) highlights the benefits of total knee replacement (TKR) in elderly patients with osteoarthritis, including a lower probability of heart failure and mortality.
Researchers at the Universit- Laval Faculty of Medicine, the Quebec Heart and Lung Institute Research Center, and the Institute of Nutrition and Functional Foods have discovered a natural molecule that could be used to treat insulin resistance and type 2 diabetes.
› Verified 7 days ago
| Entity Name | Spinecare Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184695694 PECOS PAC ID: 5496649493 Enrollment ID: O20040211000179 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.
If videogames like "Madden NFL" didn't exist, 12-year-old Tom might go outside and toss around a real football - and he'd have a better chance of sprinting for a touchdown without getting winded.
New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) highlights the benefits of total knee replacement (TKR) in elderly patients with osteoarthritis, including a lower probability of heart failure and mortality.
Researchers at the Universit- Laval Faculty of Medicine, the Quebec Heart and Lung Institute Research Center, and the Institute of Nutrition and Functional Foods have discovered a natural molecule that could be used to treat insulin resistance and type 2 diabetes.
› Verified 7 days ago
| Entity Name | Simonmed Imaging Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477830818 PECOS PAC ID: 6608036108 Enrollment ID: O20120320000846 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.
If videogames like "Madden NFL" didn't exist, 12-year-old Tom might go outside and toss around a real football - and he'd have a better chance of sprinting for a touchdown without getting winded.
New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) highlights the benefits of total knee replacement (TKR) in elderly patients with osteoarthritis, including a lower probability of heart failure and mortality.
Researchers at the Universit- Laval Faculty of Medicine, the Quebec Heart and Lung Institute Research Center, and the Institute of Nutrition and Functional Foods have discovered a natural molecule that could be used to treat insulin resistance and type 2 diabetes.
› Verified 7 days ago
| Entity Name | Vymed Diagnostic Imaging Tampa Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770579732 PECOS PAC ID: 8426006834 Enrollment ID: O20120507000682 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.
If videogames like "Madden NFL" didn't exist, 12-year-old Tom might go outside and toss around a real football - and he'd have a better chance of sprinting for a touchdown without getting winded.
New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) highlights the benefits of total knee replacement (TKR) in elderly patients with osteoarthritis, including a lower probability of heart failure and mortality.
Researchers at the Universit- Laval Faculty of Medicine, the Quebec Heart and Lung Institute Research Center, and the Institute of Nutrition and Functional Foods have discovered a natural molecule that could be used to treat insulin resistance and type 2 diabetes.
› Verified 7 days ago
| Entity Name | Professional Radiology Associates, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962521294 PECOS PAC ID: 1153585047 Enrollment ID: O20120605000338 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.
If videogames like "Madden NFL" didn't exist, 12-year-old Tom might go outside and toss around a real football - and he'd have a better chance of sprinting for a touchdown without getting winded.
New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) highlights the benefits of total knee replacement (TKR) in elderly patients with osteoarthritis, including a lower probability of heart failure and mortality.
Researchers at the Universit- Laval Faculty of Medicine, the Quebec Heart and Lung Institute Research Center, and the Institute of Nutrition and Functional Foods have discovered a natural molecule that could be used to treat insulin resistance and type 2 diabetes.
› Verified 7 days ago
| Entity Name | Smi Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972004489 PECOS PAC ID: 3476696220 Enrollment ID: O20181120002282 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.
If videogames like "Madden NFL" didn't exist, 12-year-old Tom might go outside and toss around a real football - and he'd have a better chance of sprinting for a touchdown without getting winded.
New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) highlights the benefits of total knee replacement (TKR) in elderly patients with osteoarthritis, including a lower probability of heart failure and mortality.
Researchers at the Universit- Laval Faculty of Medicine, the Quebec Heart and Lung Institute Research Center, and the Institute of Nutrition and Functional Foods have discovered a natural molecule that could be used to treat insulin resistance and type 2 diabetes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jayson A Lord, MD 212 N 2nd St, Leesburg, FL 34748-5103 Ph: (352) 435-0723 | Jayson A Lord, MD 212 N 2nd St, Leesburg, FL 34748-5103 Ph: (352) 435-0723 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.
If videogames like "Madden NFL" didn't exist, 12-year-old Tom might go outside and toss around a real football - and he'd have a better chance of sprinting for a touchdown without getting winded.
New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) highlights the benefits of total knee replacement (TKR) in elderly patients with osteoarthritis, including a lower probability of heart failure and mortality.
Researchers at the Universit- Laval Faculty of Medicine, the Quebec Heart and Lung Institute Research Center, and the Institute of Nutrition and Functional Foods have discovered a natural molecule that could be used to treat insulin resistance and type 2 diabetes.
› Verified 7 days ago
Brittany Kristen Nagy, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 E Dixie Ave Ste 104, Leesburg, FL 34748 Phone: 352-787-5858 Fax: 352-728-6749 | |
Dr. Keith Kastelic, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 E Dixie Ave, Ste 104, Leesburg, FL 34748 Phone: 352-365-2583 Fax: 352-728-6749 | |
Dr. Michael S Levine, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 E Dixie Ave, Suite 104, Leesburg, FL 34748 Phone: 352-365-2583 Fax: 352-728-6749 | |
Michael P O'neill, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 212 N 2nd St, Leesburg, FL 34748 Phone: 352-435-0723 | |
Dr. Amir Ali Hameedi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 E Dixie Ave, Suite 104, Leesburg, FL 34748 Phone: 352-365-2583 | |
Dr. Cathrine Elena Keller, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 E Dixie Ave, Suite 104, Leesburg, FL 34748 Phone: 352-365-2583 Fax: 352-728-6749 | |
Dr. Manoj Bhatia, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 E Dixie Ave, Suite 104, Leesburg, FL 34748 Phone: 352-365-2583 Fax: 352-728-6749 |